Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD). - Bissonnette R; Goleva E; Berdyshev E; Garcia S; Ramirez-Gama M; Taylor PA; Bologna G; Praestgaard AH; Chen L; Levit NA; Zahn J; Rossi AB; et al. (Journal of the American Academy of Dermatology, 2025)